Evidence map›Paper›PMID 34827305›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant

Hongbing Jia, Yuhui Xu, Zhaogang Sun

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hongbing JiaBeijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing 101149, China.
Yuhui XuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing 100700, China.
Zhaogang SunBeijing Key Laboratory in Drug Resistant Tuberculosis Research, Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing 101149, China.

Funding

Beijing Municipal Natural Science Foundation 21JG0034Key Clinical Specialty Project from Beijing Municipal Science & Technology Commission Z181100001718181National Natural Science Foundation 81871691
6 · The paper itself

Abstract

As the causative bacteria of tuberculosis,

Indexed as

drug-susceptibility testingmultidrug resistancemutationMycobacterium tuberculosis

Identifiers

PMID34827305
PMCPMC8614678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.